首页> 外文期刊>American journal of therapeutics >Comparison of 3-Factor Versus 4-Factor Prothrombin Complex Concentrate With Regard to Warfarin Reversal, Blood Product Use, and Costs
【24h】

Comparison of 3-Factor Versus 4-Factor Prothrombin Complex Concentrate With Regard to Warfarin Reversal, Blood Product Use, and Costs

机译:3因子与4因素凝血酶素复合物的比较关于华法林逆转,血液产品使用和成本

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Prothrombin complex concentrates (PCCs) are drug products containing varying amounts of vitamin K-dependent coagulation factors II, VII, IX, and X. The evidence comparing 3-factor PCC (3-PCC) versus 4-factor PCC (4-PCC) for warfarin reversal is conflicting. It has been hypothesized that 3-PCC may be less effective than 4-PCC because of relatively lower factor VII content.
机译:背景:凝血酶原浓缩物(PCCs)是含有不同量的维生素K依赖性凝血因子II,VII,IX和X的药物产品。比较3因子PCC(3-PCC)与4因子PCC(4- Warfarin Reversal的PCC)是冲突的。 已经假设,由于相对较低的因子VII含量,3-PCC可能比4-PCC更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号